ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
6,032.38
0.56%
US Tech 100
20,389.60
0.88%
Dow Jones
44,910.65
0.42%
Brent Oil
71.98
-0.08%
Bitcoin
96,173.15
-1.35%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Trinity Biotech PLC (TRIB)

  7. Trinity Biotech PLC (TRIB) News

TRIB

Trinity Biotech (TRIB)

Trinity Biotech PLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TRIB
DateTimeSourceHeadlineSymbolCompany
11/29/20244:45PMEdgar (US Regulatory)Form F-3/A - Registration statement by foreign private issuers: [Amend]NASDAQ:TRIBTrinity Biotech PLC
11/15/20245:00PMEdgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:TRIBTrinity Biotech PLC
11/15/20241:22PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
11/15/20249:00AMGlobeNewswire Inc.Trinity Biotech Announces Q3 2024 Financial ResultsNASDAQ:TRIBTrinity Biotech PLC
11/14/20245:26PMEdgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:TRIBTrinity Biotech PLC
11/07/202412:33PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
11/07/20248:19AMGlobeNewswire Inc.Trinity Biotech Regains Compliance with Nasdaq Listing RequirementsNASDAQ:TRIBTrinity Biotech PLC
10/25/20241:24PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
10/25/20241:23PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
10/25/20248:45AMGlobeNewswire Inc.Trinity Biotech Enters Oncology Space with Acquisition of Prostate Cancer Focused EpiCaptureNASDAQ:TRIBTrinity Biotech PLC
10/25/20248:45AMGlobeNewswire Inc.Trinity Biotech Announces Strategic Investment in Novus Diagnostics to Advance Rapid Sepsis Testing PlatformNASDAQ:TRIBTrinity Biotech PLC
10/07/202410:35AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
10/07/20248:15AMGlobeNewswire Inc.Trinity Biotech Announces Positive Pre-Pivotal Trial Results for Its Next-Generation Continuous Glucose Monitor TechnologyNASDAQ:TRIBTrinity Biotech PLC
10/02/202411:22AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
09/30/20243:07PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
09/25/20246:01AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
09/24/20244:05PMGlobeNewswire Inc.Trinity Biotech Announces Acquisition of Metabolomics Diagnostics to Grow Presence in Maternal Health MarketNASDAQ:TRIBTrinity Biotech PLC
09/23/20248:11AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
09/20/20245:14PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TRIBTrinity Biotech PLC
09/19/20246:01AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
09/18/20244:05PMGlobeNewswire Inc.Trinity Biotech to Initiate CGM Market Study in India in Furtherance of Intended Collaboration with BayerNASDAQ:TRIBTrinity Biotech PLC
09/10/202410:35AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
09/09/20244:05PMGlobeNewswire Inc.Trinity Biotech Provides an Update on the Continued Development of Its Continuous Glucose Monitor TechnologyNASDAQ:TRIBTrinity Biotech PLC
09/05/20241:26PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
09/05/202410:52AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
09/04/202411:59AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
09/03/20249:55AMGlobeNewswire Inc.Trinity Biotech Appoints Global Life Sciences Leader as Chief Commercial OfficerNASDAQ:TRIBTrinity Biotech PLC
08/29/20246:01AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
08/28/20245:11PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TRIBTrinity Biotech PLC
08/27/202412:33PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
 Showing the most relevant articles for your search:NASDAQ:TRIB

Your Recent History

BIT
P1PWE5
BNP Paribas Issuance
BOV
T1DG34R
Transdigm
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 50%* for Small Cap Pro

1 year 30%, 2 years 40% and *3 years 50%

*Across 3 years $2158.56 only $1079.28